🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In 3 months (and zero days), we have the inaugural Mayo Clinic #florida #autoimmune #neurology meeting. 1.5 days of great speakers and 0.5 days to spend on the beautiful Jacksonville beach 🏖️ Please sign up now ✍️ ce.mayo.edu/neurology-and-… Mayo Clinic Neuro Dr. Alfredo Quiñones-Hinojosa

Reminder to all interested in #autoimmune #neurology Please join us ce.mayo.edu/neurology-and-… For great weather, faculty talks and networking….. This will be a small, focused meeting for you to develop your knowledge and skills in #autoimmune #neurology

Looking forward to connecting with friends and colleagues at the 2025 #AANAM. Great science ahead!

Distinctive characteristics like hallucinations, cortical visual loss, advanced brain atrophy, and periodic epileptiform discharges on EEG could help diagnose rapidly progressive dementia. #AANAM25 Gregory Day @AANMember #NeuroTwitter hubs.la/Q03g7jNM0

Precision approaches to #Alzheimer disease and related disorders take the main stage at #AANAM, with my outstanding colleague, Nilufer Ertekin-Taner, MD, PhD. Moving the field towards precise and personal treatments for neurodegenerative brain disease!

It’s a Mayo Clinic, Mayo Clinic Neuro plenary at the #AANAM with W David Freeman, MD, FNCS, FAAN honing in on the role of pharmacogenomics and other precision approaches to improve the care of the individual patient.

Missed #AANAM25? Check out top abstracts’ highlights. Hallucinations, cortical visual loss, brain atrophy, and EEG discharges could help diagnose rapidly progressive dementia. #AANAM25 Gregory Day @AANMember #NeuroTwitter hubs.la/Q03hjhTk0

Honored to see our STAM3P score make the educational short-list! One more step towards our goal of improving the diagnosis and care of patients with rapid progressive dementia. Nihal Satyadev, MD, MPH Philip Tipton, M.D.

Beware commercial tissue based assays (TBAs) to detect cell surface autoantibodies in neurology. TBAs are often used as screening tests and are reader dependent. Bottom line: please think clinically when diagnosing autoimmune neurological syndromes pubmed.ncbi.nlm.nih.gov/40393020/

Just published 👉 A NEWLY updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote 🧠🔥 Why is this paper so important ? 1/

Mayo Clinic researchers have affirmed the accuracy of a blood test to diagnose Alzheimer's disease at outpatient memory clinics. Read more: mayocl.in/3FILpa6 Gregory Day Yoav Piura

Alzheimer’s blood test can spot people with early symptoms, Gregory Day et al study suggests theguardian.com/society/2025/j… via PA Media Robert Howard